Qvanteq develops novel biofunctional surfaces to address and overcome the clinical adverse effects of today’s medical devices and vascular stents. The Qstent technology is antithrombotic and results in reduced inflammatory response.
Employees: 1-10
Total raised: $4.36M
Founded date: 2009
Investors 3
| Date | Name | Website |
| - | Verve Vent... | verve.vc |
| - | Venture Ki... | venturekic... |
| - | VentureLab | venturelab... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 12.02.2013 | Series B | $4.36M | - |
Mentions in press and media 15
| Date | Title | Description | Source |
| 08.07.2015 | Schweizer Startups wollen China erobern | Schweizer Startups wollen China erobern 08.07.2015 14:00, Nicolas Bopp linkedIn facebook twitter ins... | venturelab... |
| 08.07.2015 | Die venture leaders China stehen fest | Für Schweizer Startups ist China einer der wichtigsten Märkte. Inspiriert von dem Erfolgsmodell de... | startuptic... |
| 22.04.2015 | Red Herring announces European winners | The Red Herring Top 100 Europe Awards is given out yearly to the 100 most innovative and promising... | startuptic... |
| 10.04.2015 | Twelve Swiss Start-ups Selected for RedHerring Europe | The Red Herring Top 100 award highlights the most exciting start-ups from Asia, Europe and the Ame... | startuptic... |
| 16.12.2014 | IMD announces Start-up Competition Winners | Created in 1999, the IMD start-up competition provides a good opportunity for regional start-ups t... | startuptic... |
| 25.11.2014 | Swiss coronary stent company Qvanteq enrolled first patient ... | “Enrolling the first patient is a significant step towards clinical proof of concept for our bioac... | startuptic... |
| 03.09.2014 | CTI Swiss Medtech Award 2014: Using ultra sound instead of c... | Gábor Székely, Head of CTI Medtech, presented Orçun Göksel (ETHZ) and Markus Widmer (Veinpress Gmb... | startuptic... |
| 16.01.2014 | Application open for venture leaders | Each year more than 100 startups apply to participate in this unique program. 40 of these companie... | startuptic... |
| 12.02.2013 | Qvanteq closes series B financing round of CHF4 million | Qvanteq AG is a Zurich, Switzerland, based medtech startup company. Pre-clinical in vivo studies w... | startuptic... |
| 07.12.2012 | More start-ups than ever at the Swiss Venture Day | It was a hard day for the 40+ investors and business angels: They saw presentations of eight very ... | startuptic... |
Show more